Bexarotene Capsule, Liquid Filled
Product Images NDC 0378-6955

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bexarotene (NDC 0378-6955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bexarotene Capsules 75 mg Bottle Label (Image 01)

Bexarotene Capsules 75 mg Bottle Label (Image 01)
Bexarotene Capsules is a medication that is dispensed with a patient information leaflet, which has details about the usage of the drug. Each capsule of Bexarotene Capsules contains 75mg of Bexarotene, and the inactive ingredients are polyethylene glycol 400, NF, polysorbate 20, NF, povidone, USP, and butylated hydroxyanisole, NF. The capsule shell contains gelatin, NF, water, sorbitol sorbitan solution, NF, glycerin, USP, and titanium dioxide, USP, and the imprinting ink contains hypromellose, USP, iron oxide black, and polyethylene glycol, USP. The usual dosage instructions are present in the package insert, and Bexarotene Capsules need to be stored between 2° to 25°C (36° to 77°F) away from high temperatures, humidity, and light. This medication is manufactured by Patheon Softgels, Inc. in High Point, NC, and is marketed by Mylan Pharmaceuticals Inc. in Morgantown, WV, USA.*
FDA Label Image

Bexarotene Structural Formula (Image 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.